Top Markets
Coin of the day
Allena Pharmaceuticals, Inc. Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc.

ALNAQ
Ранг среди акций #42825
Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on... Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on unearthing, developing, and marketing oral enzyme therapies. These treatments are devised to assist patients in the United States afflicted by uncommon and serious metabolic as well as renal conditions. Central to its pipeline is ALLN-346, an innovative enzyme designed to degrade urate, targeting hyperuricemia and gout in individuals with advanced chronic kidney disease. The company, which commenced operations in 2011 and has its main office in Newton, Massachusetts, made headlines on September 2, 2022, by seeking voluntary reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Цена акции
$0.000001
Последняя синхронизация: 2023-12-13
Рыночная капитализация
$23.51
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Allena Pharmaceuticals, Inc. (ALNAQ)

Категория

Коэффициент P/S для Allena Pharmaceuticals, Inc. (ALNAQ)
Коэффициент P/S на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Allena Pharmaceuticals, Inc., текущий коэффициент P/S (TTM) составляет 0. В конце 2026 он составлял 0.
История P/S для Allena Pharmaceuticals, Inc. с 2026 по 2026
Коэффициент P/S в конце каждого года
Год P/S Изменить
Недостаточно данных для указанных дат.
Коэффициент P/S для аналогичных компаний или конкурентов
Компания P/S Разница P/S Страна
9.88 -
US
10.30 -
NL
- -
CH
4.98 -
BE
- -
KR